Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Qualification of Analytical Balances – V 2.0

Posted on By

Analytical Method Development: SOP for Qualification of Analytical Balances – V 2.0

Standard Operating Procedure for Qualification of Analytical Balances in Method Development


Department Analytical Method Development
SOP No. SOP/AMD/347/2025
Supersedes SOP/AMD/347/2022
Page No. Page 1 of 14
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to describe the procedure for the qualification of analytical balances used in the Analytical Method Development (AMD) laboratory. This includes Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification

(PQ) to ensure balance reliability, accuracy, and GMP compliance.

2. Scope

This SOP applies to all new or relocated analytical balances intended for use in the AMD department, and for balances undergoing requalification after maintenance or calibration deviations.

3. Responsibilities

  • AMD Analyst: Initiates the qualification protocol and assists in execution.
  • Engineering/Maintenance: Performs installation and provides utility confirmation.
  • QA Representative: Reviews and approves qualification documents.
  • External Vendor (if applicable): Supports traceable calibration and validation services.
See also  Analytical Method Development: SOP for Linearity and Range Evaluation - V 2.0

4. Accountability

The AMD Manager is accountable for ensuring all balances used in method development are properly qualified, maintained, and documented according to cGMP requirements.

5. Procedure

5.1 Installation Qualification (IQ)

  1. Verify physical condition of the balance upon delivery (model, serial number, accessories).
  2. Install in vibration-free, draft-protected location with calibrated spirit level.
  3. Document environmental conditions such as temperature, humidity, and electromagnetic interference.
  4. Check electrical connections, printer ports, and level bubble alignment.
  5. Affix ‘Qualified Equipment’ label post verification.

5.2 Operational Qualification (OQ)

  1. Ensure internal and external calibration options function as per manufacturer’s instructions.
  2. Verify repeatability using standard certified weights (e.g., 10 mg, 100 mg, 1 g, 10 g).
  3. Perform eccentricity testing by placing weights at different positions on the pan.
  4. Test linearity across the range using certified weights in ascending/descending order.
  5. Document readings, tolerance limits, and observations in Annexure-1.
See also  Analytical Method Development: SOP for Qualification of Reference Standards - V 2.0

5.3 Performance Qualification (PQ)

  1. Evaluate day-to-day accuracy using internal calibration and two external certified weights.
  2. Run PQ for three non-consecutive days using same weights by different analysts.
  3. Acceptable criteria: % deviation ≤ ±0.1% from standard weight value.
  4. Ensure environmental stability during performance checks.

5.4 Post Qualification Steps

  1. Compile IQ, OQ, PQ results into a Qualification Summary Report (Annexure-2).
  2. Forward the report to QA for review and sign-off.
  3. Update Equipment Master List and Calibration Plan Register.
  4. Label the balance with “Qualified”, “Calibrated” and “Next Due” stickers.

5.5 Requalification Criteria

  • Relocation to another room/facility
  • Post-maintenance or software upgrade
  • Major deviation in calibration or failed test during routine checks

6. Abbreviations

  • IQ: Installation Qualification
  • OQ: Operational Qualification
  • PQ: Performance Qualification
  • cGMP: Current Good Manufacturing Practice

7. Documents

  1. Annexure-1: OQ Data Sheet
  2. Annexure-2: Qualification Summary Report
  3. Annexure-3: Calibration Certificate (External Vendor)

8. References

  • ICH Q9 – Quality Risk Management
  • USP General Chapter < 41 > Weights and Balances
  • 21 CFR Part 211 – Current GMP for Finished Pharmaceuticals
See also  Analytical Method Development: Method Development for Particle Size Analysis - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Sneha Joshi Rohit Sharma Dr. Kavita Mehra
Designation AMD Analyst QA Executive Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: OQ Data Sheet

Weight Used Nominal Value Observed Value % Deviation Status
Certified Weight 1 10 mg 9.998 mg -0.02% Pass
Certified Weight 2 100 mg 100.001 mg +0.001% Pass

Annexure-2: Qualification Summary Report

Summarizes IQ, OQ, and PQ completion dates, responsible personnel, observations, deviations (if any), and final approval.

Annexure-3: Calibration Certificate

Provided by NABL-accredited third-party calibration agency with traceability details and validity period.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Added detailed PQ procedure and documentation controls Annual SOP Review Dr. Kavita Mehra
01/04/2022 1.0 Initial Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Conducting Inter-Laboratory Analytical Method Comparability – V 2.0
Next Post: Elixir Department: SOP for Deviation Management – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version